Logo

Cancer

The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.

TUM Researchers Profiling Dose-Dependent Response of Protein PTMs to Cancer Drugs
Premium

The scientists believe this information could help unravel drug modes of action and potentially help doctors tailor treatments based on patient proteomic profiles.

Medulloblastoma Long-Read Sequences Reveal Complex Rearrangements, Methylation Changes

With Oxford Nanopore sequencing, researchers found DNA methylation clues and complex rearrangement patterns that were subsequently assessed in a broader cancer set.

Onconova Therapeutics, Pangea Biomed Collaborate on AI-Driven Cancer Biomarker Study

The companies will apply Pangea's ENLIGHT platform to map gene interactions in pathways modulated by Onconova's investigational cancer therapy rigosertib.

Baylor Team Aims to Identify Chemo Toxicity Biomarkers in Latino Pediatric Leukemia Patients
Premium

The CPRIT-funded study will examine clinical and genomic data from more than 2,000 Latino patients with acute lymphoblastic leukemia treated with high-dose chemo.

BostonGene, Little Warrior Foundation Partner to Develop Sarcoma-Specific Liquid Biopsy

Liquid biopsy tests will be designed to detect molecular alterations and fusions specific to sarcoma using cell-free DNA and RNA.

Mar 22, 2023

Reveal Genomics Eyes 2024 Launch for Liquid Biopsy Test to Guide Breast Cancer Treatment
Premium

Mar 22, 2023

Massive Bio, NeoGenomics Collaborate on AI-Driven Oncology Clinical Trial Matching

Mar 21, 2023

Previse Launches Esophageal Cancer Risk Test, Raises $3M to Support Commercial Expansion

Mar 21, 2023

Guardant Health, Ohio State University Partner on Blood-Based Colon Cancer Screening Study

Mar 20, 2023

Oxford Nanopore Technologies, 4bases Collaborate to Develop Rapid BRCA Sequencing Test

Mar 17, 2023

Advanced Cancer Outcomes Predicted Using Model Based on Circulating Tumor DNA Metrics

Mar 16, 2023

Researchers Aim to Boost Liquid Biopsy cfDNA Yields Using Novel Priming Agents
Premium

Mar 16, 2023

Johns Hopkins Team Using Long-Read Sequencing to Crack Genetic Code of Pancreatic Cancer
Premium

Mar 16, 2023

GenoMe Diagnostics Preparing Digital PCR-Based Ovarian Cancer Test for US, EU, UK Submissions 
Premium

Mar 16, 2023

Australia's Genetic Technologies Seeks Private Payor Coverage to Bring Polygenic Risk Tests to US
Premium

Mar 16, 2023

Droplet Biosciences Targets Lymph Fluid in New Residual Cancer Detection Strategy
Premium

Mar 15, 2023

Researchers Find Genetic, Cellular Features of Early-Onset Colorectal Cancer in Chinese Patients

Mar 15, 2023

Protai Expands Seed Round to $20M

Mar 15, 2023

Mainz Biomed Partners With Labor Staber to Market ColoAlert Test

Mar 14, 2023

Stanford's CytoSPACE Looks to Improve Single-Cell Transcriptomics Alignment
Premium

Mar 14, 2023

Sophia Genetics, Agilent Partner on Cancer Analysis Product

Mar 14, 2023

Neogap Therapeutics, Simsen Diagnostics Collaborate on Cancer Dx

Mar 13, 2023

Gastric Cancer Driver Analysis Leads to Ancestry-, Subtype-Specific Features

Mar 13, 2023

Ocean Genomics Sees Accenture Ventures Investment as Ticket to Big Pharma
Premium

Mar 10, 2023

BioMérieux, Biocartis, Beckman Coulter Gain FDA 510(k) Clearances in February

Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.